1Suzuki S,Shigeo N.Malignancies of natural killer (NK) cell precursor:myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leulemia[J].Leuk Res,1999,23(7):615-624.
2Jaffe E S,Harris N L,Diebold J,et al.World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues:Report of the clinical advisory committee meeting,airlie house,Virginia.November 1997[J].Histopathology,2000,36(1):69-86:
3Bayerl M G,Rakozy C K,Mohamed A N,et al.Blastic natural killer cell leukemia/lymphoma:a report of seven cases [J].Am J Pathol,2002,117(1):41-50.
4DiGiuseppe J A,Louie D C,Williams J E,et al.Blastic natural killer cell leukemia/ lymphoma:a clinicopathologic study [J].Am J Surg Pathol,1997,21(10):1223-1330.
5Jaffe E S,Chan J K,Su I,et al.Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas[J].Am J Surg Pathol,1996,20(1):103-111.
6Hart D N,Baker B W,Inglis M J,et al.Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cell[J].Blood,1992,79(8):2116-2123.
8Spits H,Blom B,Jeleo A C,et al.Early stages of the development of human T,natural killer and thymic dendritic cells [J].Immunol Rev,1998,165(1):75-86.
9Siu L L P,Wong K F,Kwong Y L,et al.Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia[J].Am J Pathol,1999,155(5):1419-1425.
10Siu L L,Chan J K,Wong K F,et al.Aberrant promoter CpG methy-.lation as a molecular maker for disease monitoring in natural killer cell lymphomas[J].Br J Haematol,2003,122(1):70-77.
